Boston Scientific (BSX)

EBITDA Margin

27.77%

Quarterly · Period ending:

BSX logo

BSX EBITDA Margin

Latest reported27.77%
BSX Quarterly EBITDA Margin (100.00% → 27.77%)
High-resolution chart · PNG

BSX ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Boston Scientific EBITDA Margin — Quarterly
Period endingEBITDA Margin
13.9881%
21.7125%
39.185%
28.8344%
30.9353%
29.8969%
42.2594%
21.4182%
32.7824%
31.3559%
-71.2674%
22.593%
22.9385%
23.617%
7.8264%
26.2216%
29.3012%
28.2565%
5.4808%
29.1945%
48.0123%
53.3809%
13.2189%
33.8058%
33.084%
34.3996%
31.0855%
28.3422%
27.9345%
28.2051%
33.5312%
29.7071%
29.2373%
28.1215%
31.6351%
31.2576%
30.4063%
30.303%
-150%
100%
100%
100%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.